Health Idea Now
Thursday, 1 November 2018
FDA panel votes against Alkermes' depression treatment
An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approving Alkermes Plc's experimental depression treatment.
from Reuters: Health News https://ift.tt/2JxEPBS
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment